AngioScore
Latest round
- Series F
Last raised
- Apr 2011
Total raised
- $88M
Investors
- 8
About AngioScore
AngioScore, Inc.AngioScore, Inc. was founded in 2003 and is headquartered in Fremont, US. The company develops medical technologies aimed at enhancing cardiac and vascular care.000 mn.AngioScore’s products focus on lead management devices and extraction sheaths, essential for managing cardiac implantable electronic device (CIED) infections.AngioScore generates revenue through direct sales of its medical devices to healthcare institutions, specifically hospitals and specialized clinics. The pricing of their products varies based on device complexity, with a strong emphasis on quality and reliability in meeting healthcare demands.Following its acquisition by Spectranetics Corporation, AngioScore is positioned for growth through the development of new products and solutions tailored for cardiovascular care. The strategic acquisition will leverage Spectranetics’ resources to enhance product offerings and expand into new geographic markets, including Europe and Asia, by 2025.000 mn from the acquisition will support these initiatives, facilitating research and product development aimed at improving healthcare outcomes.
Who invested in AngioScore
8 investors across 4 rounds
See all investors in AngioScore
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AngioScore
Who invested in AngioScore?
AngioScore has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AngioScore raised?
AngioScore has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did AngioScore last raise money?
AngioScore's most recent round on record is a Series F, in Apr 2011.
What does AngioScore do?
AngioScore is a medical devices & equipment company.
Where is AngioScore headquartered?
AngioScore is headquartered in Fremont, US.
Which VCs invest in companies like AngioScore?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at AngioScore's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series F
Raising like AngioScore? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.